Case Reports

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma

Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Jerome Lipper Multiple Myeloma Center, Division of Plasma Cell Neoplasias, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Department of Pathology, Molecular, and Cell-Based Medicine, Molecular Microbiology Laboratory, Icahn School of Medicine at Mount Sinai, New York, New York
Department of Pathology, Molecular, and Cell-Based Medicine, Molecular Microbiology Laboratory, Icahn School of Medicine at Mount Sinai, New York, New York
Department of Pathology, Molecular, and Cell-Based Medicine, Molecular Microbiology Laboratory, Icahn School of Medicine at Mount Sinai, New York, New York
Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Tisch Cancer Center, Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Haematologica Early view Jul 2, 2026 https://doi.org/10.3324/haematol.2026.300894